SR
Srinivasa Rao Gandupalli
About Srinivasa Rao Gandupalli
Data last updated:
Srinivasa Rao Gandupalli is a Director at Rithika Pharmaceuticals Private Limited (since 2018) and Director at Sree Rithika Laboratories Private Limited (since 2020). The companies operate in Business Services and Chemicals. The largest current company by reported revenue is Rithika Pharmaceuticals Private Limited at ₹21.7 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2018 | 2018 | ₹21.7 Lakh (FY 2019) | Active | |
| Director | 27 Jan 2020 | 2020 | Active |
Board colleagues of Srinivasa Rao Gandupalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gandupalli Eswari | 08533380 | Rithika Pharmaceuticals Private Limited , Sree Rithika Laboratories Private Limited | Director |
| Vanisree Yandapalli | 08679858 | Sree Rithika Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasa Rao Gandupalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasa Rao Gandupalli
Srinivasa Rao Gandupalli currently holds 2 directorships: Rithika Pharmaceuticals Private Limited (Director, since 15 Feb 2018, revenue ₹21.7 Lakh (FY 2019)); Sree Rithika Laboratories Private Limited (Director, since 27 Jan 2020).
Srinivasa Rao Gandupalli was first appointed on 15 Feb 2018 as Director at Rithika Pharmaceuticals Private Limited. The most recent appointment on record is 27 Jan 2020 at Sree Rithika Laboratories Private Limited.
The current boards of Srinivasa Rao Gandupalli's companies include Gandupalli Eswari (Rithika Pharmaceuticals Private Limited), Vanisree Yandapalli (Sree Rithika Laboratories Private Limited).